XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2020   28,556,605      
Beginning balance at Dec. 31, 2020 $ 917,160 $ 29 $ 510,158 $ 408,037 $ (1,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,616     2,616  
Unrealized gain (loss) on investment, net of tax 38       38
Stock-based compensation 1,248   1,280 (32)  
Issuance of restricted and deferred stock units (in shares)   30,547      
Issuance of restricted and deferred stock units (964)   (964)    
Employee stock purchase plan (in shares)   18,235      
Employee stock purchase plan 1,026   1,026    
Common stock issuance, net of costs (in shares)   1,184,500      
Common stock issuance, net of costs 66,896 $ 1 66,895    
Dividends paid (9,724)     (9,724)  
Ending balance (in shares) at Mar. 31, 2021   29,789,887      
Ending balance at Mar. 31, 2021 $ 978,296 $ 30 578,395 400,897 (1,026)
Beginning balance (in shares) at Dec. 31, 2021 30,181,348 30,181,348      
Beginning balance at Dec. 31, 2021 $ 1,034,519 $ 30 606,392 428,260 (163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,737     3,737  
Unrealized gain (loss) on investment, net of tax (181)       (181)
Stock-based compensation 1,532   1,552 (20)  
Issuance of restricted and deferred stock units (in shares)   37,879      
Issuance of restricted and deferred stock units (1,269)   (1,269)    
Employee stock purchase plan (in shares)   17,918      
Employee stock purchase plan 1,049   1,049    
Common stock issuance costs (87)   (87)    
Dividends paid $ (10,882)     (10,882)  
Ending balance (in shares) at Mar. 31, 2022 30,237,145 30,237,145      
Ending balance at Mar. 31, 2022 $ 1,028,418 $ 30 $ 607,637 $ 421,095 $ (344)